Activity
1K followers
-
Rob Milligan reposted thisRob Milligan reposted thisIndustry experts Reena Patel, Partner, Blue Fin Group, an IntegriChain Company, Jim Meyers, Chairman of the Board, IntegriChain, Cynthia (Cyndi) Goss, Head of US Strategic Policy and Pricing, Insmed Incorporated, and Jose Luis Valdes, Executive Director of Pricing SP and Channel Strategy, Novartis, led a panel discussion at our Access Insights Conference. They explored current market access trends, highlighting the challenges and opportunities facing pharmaceutical companies today. The discussion offered a comprehensive overview of the evolving landscape, including regulatory pressures, payer strategies, and the future of the industry. Read the first installment of our two-part blog post here: https://lnkd.in/e8EKqezu
-
Rob Milligan reposted thisRob Milligan reposted thisCaitlin Fee is a valued member of our team! As Associate Director of Advisory Services, she brings invaluable expertise and dedication, specifically in helping manufacturers navigate the regulatory complexities of pricing and contracting, driving success for our clients. If you're seeking to be part of a team that values its members, explore our career opportunities here: https://lnkd.in/d6B_eKm
-
Rob Milligan reposted thisRob Milligan reposted thisWe are sponsoring the RAC Summit on March 27th at the Hilton in East Brunswick, NJ. Connect with Jen Sharpe, MBA (Molinelli), Jeffrey Baab, and other industry leaders to discuss crucial regulatory updates. Spots are limited, register today: https://lnkd.in/eAnuRsbD
-
Rob Milligan reposted thisRob Milligan reposted thisGain a competitive edge in the HCP-administered product market. Join our free webinar with Senior Principals Brett Casper and Joey Miller for expert insights on buy and bill, ASP-based reimbursement, and other critical success factors. Register today and unlock the knowledge you need to thrive: https://lnkd.in/dzbZumkX
-
Rob Milligan reposted thisRob Milligan reposted thisRegulatory changes and market shifts demand expertise in Fair Market Value and Bona Fide Service Fees. At our Access Insights Conference, experts Nicholas Lynch, CFE and Suriya Janarthanan shared how pharma manufacturers can stay ahead. Our blog highlights their key takeaways. Discover them here: https://lnkd.in/eHcjkhXq
-
Rob Milligan shared thisExciting news here at IntegriChain! Please reach out with any questions!Rob Milligan shared thisUnlock Profitable Growth with ICyteⓇ Commercial Data Suite! IntegriChain is revolutionizing pharma commercialization with the launch of the ICyte Commercial Data Suite. This platform addresses the critical issue of data fragmentation, enabling manufacturers to make data-driven decisions that boost net revenue performance and profitability. "Pharma manufacturers lack the commercial insights that help battle the headwinds of lagging net revenue performance, unprofitable growth, excessive enterprise cost, and forecast and accrual inaccuracies," says Joshua Halpern, CEO of IntegriChain. "With this new offering, we’ve combined the best-of-breed data science and technology across the breadth of first-, second-, and third-party commercial data, delivering analytics and insights that improve net revenue performance.” Key benefits include: ~Enhanced channel and patient journey analytics ~Real-time net revenue visibility ~Integrated sales and marketing reporting Discover how ICyte can transform your commercial strategy: https://lnkd.in/eeCFeZvW
-
Rob Milligan shared thisDon't miss this opportunity! Register now to secure your spot. Reach out with any questions.Rob Milligan shared thisJoin @BharatLakshmi and @JeffBaab on February 25th at 1 PM EST for a webinar on Navigating the Medicare Drug Price Negotiation Landscape. The discussion will cover the impact of IPAY 2027, strategic considerations for manufacturers, and the evolving healthcare ecosystem. Register here: [Link to register] #MedicareDrugPricing #IRA #Pharmaceuticals
-
Rob Milligan shared thisMeet out new CCO Tim Murdoch!Rob Milligan shared thisWe’re thrilled to share the story of Tim Murdoch, IntegriChain’s new Chief Commercial Officer, who brings a wealth of experience from his time with industry giants like Adobe, Salesforce, and SAP. As he joins us in our mission to transform pharma commercialization, Tim reflects on the journey from tech leaders to an industry deeply focused on patient access and net revenue optimization. Read more about Tim’s vision for the future of pharma commercialization and his transition into pharma commercialization in our latest blog post: https://lnkd.in/eudxA6CM
-
Rob Milligan reposted thisRob Milligan reposted thisIntegriChain is passionate about Government Pricing! We are looking for those who have that same passion and have GP in their DNA - you know you who are! We are continually striving to build upon our world-class team of GP professionals. We have exciting opportunities throughout IntegriChain - from assisting the pharma world with analysis, consulting, ongoing services, systems design and even building innovative technology into our ICyte platform! Contact me directly if you are interested in learning more!
-
Rob Milligan liked thisRob Milligan liked thisBryan's commitment helps make members feel seen and valued on their healthcare journey.
-
Rob Milligan liked thisRob Milligan liked thisHad an awesome time with the Spencer's Roswell, NM team this past weekend, turning the store into an Oasis in the Desert! 🌵🛍️ The energy from both the team and our customers was out of this world. Huge thanks to everyone who made it such a fun and memorable event—hope to see you all again soon... 👽🚀 #Spencers #InStoreExperience #RoswellNM #Teamwork #RetailEvents #OutOfThisWorld
-
Rob Milligan liked thisRob Milligan liked thisIndustry experts Reena Patel, Partner, Blue Fin Group, an IntegriChain Company, Jim Meyers, Chairman of the Board, IntegriChain, Cynthia (Cyndi) Goss, Head of US Strategic Policy and Pricing, Insmed Incorporated, and Jose Luis Valdes, Executive Director of Pricing SP and Channel Strategy, Novartis, led a panel discussion at our Access Insights Conference. They explored current market access trends, highlighting the challenges and opportunities facing pharmaceutical companies today. The discussion offered a comprehensive overview of the evolving landscape, including regulatory pressures, payer strategies, and the future of the industry. Read the first installment of our two-part blog post here: https://lnkd.in/e8EKqezu
-
Rob Milligan liked thisRob Milligan liked thisCaitlin Fee is a valued member of our team! As Associate Director of Advisory Services, she brings invaluable expertise and dedication, specifically in helping manufacturers navigate the regulatory complexities of pricing and contracting, driving success for our clients. If you're seeking to be part of a team that values its members, explore our career opportunities here: https://lnkd.in/d6B_eKm
-
Rob Milligan liked thisRob Milligan liked thisFantastic night celebrating Camp Sunshine, programs for kids with cancer, at the Sunshine Spectacular 2025! I've served as Board Chair for the past two years and have spent a week during each of the last 27 summers as a counselor at camp. I look forward to many more years of serving these kids and their families. #cancersucks #COCA
-
Rob Milligan liked thisRob Milligan liked thisWe are sponsoring the RAC Summit on March 27th at the Hilton in East Brunswick, NJ. Connect with Jen Sharpe, MBA (Molinelli), Jeffrey Baab, and other industry leaders to discuss crucial regulatory updates. Spots are limited, register today: https://lnkd.in/eAnuRsbD
Experience
-
-
-
-
-
-
-
-
-
-
-
Education
-
Saint Joseph's University
-
-
-
-
-
Other similar profiles
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content